Skip to main content
OpenTrials

Clinical trial condition

Virus Diseases

Explore clinical trials studying Virus Diseases. Study availability and eligibility vary by location and protocol.

18,936 public trials 1,286 recruiting studies
Refine in advanced search Browse all conditions

Virus Diseases trial results

Active, Not Recruiting

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

NCT04488081

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC Davis Medical Center Davis, California, United States
  • UC Irvine Medical Center Irvine, California, United States
  • Long Beach Memorial Medical Center Long Beach, California, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19

NCT07279766

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte Hellerup, Denmark
  • Danske Lægers Vaccinations Service Søborg, Denmark
View Trial Details
Active, Not Recruiting

A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)

NCT05996471

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)

NCT07293065

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • Hebei Provincial Center for Disease Control and Prevention Shijiazhuang, Hebei, China
  • Henan Center for Diseases Control and Prevention Zhengzhou, Henan, China
  • Hubei Provincial Center for Disease Control and Prevention Wuhan, Hubei, China
  • Yunnan Center For Disease Control and Prevention Kunming, Yunnan, China
View Trial Details

Related conditions